Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trp-lys-tyr-met-val-met

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with trp-lys-tyr-met-val-met in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(trp-lys-tyr-met-val-met)
Trials
(trp-lys-tyr-met-val-met)
Recent Studies (post-2010) (trp-lys-tyr-met-val-met)
9,15618755292138

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bylund, J; Dahlgren, C; Fu, H; Karlsson, A; Pellmé, S1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and trp-lys-tyr-met-val-met

ArticleYear
The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
    Immunology, 2004, Volume: 112, Issue:2

    Topics: Adult; Cells, Cultured; Chemotactic Factors; Chemotaxis, Leukocyte; Cytoskeleton; Enzyme Activation; Humans; Interleukin-8; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oligopeptides; Platelet Activating Factor; Receptors, Formyl Peptide; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Signal Transduction; Tumor Necrosis Factor-alpha

2004